Trial Profile
Randomized, double-blind, placebo-controlled trial of efficacy of mometasone furoate nasal spray in the initial treatment of Japanese cedar pollinosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Feb 2013
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Allergic rhinitis; Hypersensitivity
- Focus Therapeutic Use
- 11 Feb 2013 Actual end date changed from 1 Dec 2010 to 1 Sep 2011 as reported by University Hospital Medical Information Network - Japan record.
- 18 Jul 2011 New trial record